Synthesis of novel alpha-pyranochalcones and pyrazoline derivatives as Plasmodium falciparum growth inhibitors.
Both the lack of a credible malaria vaccine and the emergence and spread of parasites resistant to most of the clinically used antimalarial drugs and drug combination have aroused an imperative need to develop new drugs against malaria. In present work, alpha-pyranochalcones and pyrazoline analogs were synthesized to discover chemically diverse antimalarial leads. Compounds were tested for antimalarial activity by evaluation of the growth of malaria parasite in culture using the microtiter plate based SYBR-Green-I assay. The (E)-3-(3-(2,3,4-trimethoxyphenyl)-acryloyl)-2H-chromen-2-one (Ga6) turned out to be the most potent analog of the series, showing IC(50) of 3.1 microg/ml against chloroquine-sensitive (3D7) strain and IC(50) of 1.1 microg/ml against chloroquine-resistant field isolate (RKL9) of Plasmodium falciparum. Cytotoxicity study of the most potent compounds was also performed against HeLa cell line using the MTT assay. All the tested compounds showed high therapeutic indices suggesting that they were selective in their action against the malaria parasite. Furthermore, docking of Ga6 into active site of falcipain enzyme revealed its predicted interactions with active site residues. This is the first instance wherein chromeno-pyrazolines have been found to be active antimalarial agents. Further exploration and optimization of this new lead could provide novel, antimalarial molecules which can ward off issues of cross-resistance to drugs like chloroquine.
Wanare
Gajanan
G
Department of Pharmacy, Shri G.S. Institute of Technology and Science, Indore, MP 452003, India. gajananwanare@gmail.com
Aher
Rahul
R
Kawathekar
Neha
N
Ranjan
Ravi
R
Kaushik
Naveen Kumar
NK
Sahal
Dinkar
D
D000962:Antimalarials / Q000138:chemical synthesis* / Q000737:chemistry / Q000633:toxicity; D001665:Binding Sites; D047188:Chalcones / Q000138:chemical synthesis / Q000737:chemistry* / Q000633:toxicity; D003198:Computer Simulation; D003546:Cysteine Endopeptidases / Q000737:chemistry; D006367:HeLa Cells; D006801:Humans; D010963:Plasmodium falciparum / Q000187:drug effects* / Q000254:growth & development; D011720:Pyrazoles / Q000138:chemical synthesis / Q000737:chemistry* / Q000633:toxicity; D013329:Structure-Activity Relationship
D000962:Antimalarials; D047188:Chalcones; D011720:Pyrazoles; D003546:Cysteine Endopeptidases; C099607:falcipain